Please login or register to print this page.

VIEW TAGS

Articles tagged ‘RE-LY’

September 20, 2010

Dabigatran Features In New AF Guidelines

The new European Society of Cardiology (ESC)guidelines for the management of atrial fibrillation (AF), have now included guidance on the role of a novel oral treatment, dabigatran etexilate, for the prevention of stroke and systemic embolism in patients with AF (1)

read more

March 22, 2010

New RE-LY data presented at ACC

New sub-group analysis from the landmark RE-LY study has shown dabigatran etexilate significantly reduces the risk of stroke compared to warfarin irrespective of a patient’s risk profile for stroke.

read more

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

PROUDLY SPONSORED BY

Sanofi-Aventis Medtronic Pifzer Sanofi-Aventis Medtronic Pifzer

ENDORSED BY

  • Arrhythmia Alliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.